UCB Ventures makes its first direct investment | UCB
UCB's Global Corporate Website

UCB Ventures makes its first direct investment

Picture of author Laurent Schots
Posted by
Laurent Schots, Global Communications and Company Reputation
Brussels, Belgium, 13 June 2018. — Today, UCB Ventures announces its first direct investment in the oversubscribed $15.7 million Series A Financing Round for StrideBio, Inc., a US-based biotechnology company developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies of rare diseases. 

The financing was led by Hatteras Venture Partners, and in addition to UCB Ventures, co-investors include Takeda Ventures, Inc. and Alexandria Venture Investments, LLC. Erica Whittaker, PhD, Vice President, Head of UCB Ventures, and Jayson Punwani, PhD, Partner, Takeda Ventures, Inc. have joined StrideBio’s Board of Directors.

Read more on our UCB Ventures website

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.
16 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.